abruptly Medications for Non-Small Cell Lung Cancer Other names: Cancer, Lung, Non-Small Cell; Lung Cancer, Non-Small Cell; NSCLC Health Guide Care Notes Medication List Encyclopedia Q & A More What is Non-Small Cell Lung Cancer: Non-Small Cell Lung Cancer is cancer of the lung which is not small cell carcinoma. Medications to treat Non-Small Cell Lung Cancer The following list of medications are in some way related to, or used in the treatment of this condition. Drug Class (show all) - alkylating agents (4) - antimetabolites (7) - miscellaneous antineoplastics (2) - mitotic inhibitors (8) - antirheumatics (2) - antipsoriatics (2) - antineoplastic detoxifying agents (2) - multikinase inhibitors (10) - VEGF/VEGFR inhibitors (4) - EGFR inhibitors (9) - other immunosuppressants (2) - Anti-PD-1 monoclonal antibodies (6) Rx OTC Off Label Only Generics Drug name Rx / OTC Preg nancy CSA Alcohol Reviews Rating Popularity Tarceva Rx D N 37 reviews 8.0 Generic name: erlotinib systemic Drug class: EGFR inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Avastin Rx C N 1 review 8.0 Generic name: bevacizumab systemic Drug class: VEGF/VEGFR inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Alimta Rx D N 1 review 7.0 Generic name: pemetrexed systemic Drug class: antimetabolites For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Iressa Rx D N 7 reviews 9.0 Generic name: gefitinib systemic Drug class: EGFR inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Taxol Rx D N 1 review 8.0 Generic name: paclitaxel systemic Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects For professionals: Prescribing Information Gemzar Rx D N Add review Rate Generic name: gemcitabine systemic Drug class: antimetabolites For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Opdivo Rx N 14 reviews 3.0 Generic name: nivolumab systemic Drug class: Anti-PD-1 monoclonal antibodies For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Xalkori Rx D N 3 reviews 9.0 Generic name: crizotinib systemic Drug class: multikinase inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph cisplatin Rx D N Add review 6.0 Generic name: cisplatin systemic Brand names: Platinol, Platinol-AQ Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Abraxane Rx D N Add review Rate Generic name: paclitaxel protein-bound systemic Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects Navelbine Rx D N Add review Rate Generic name: vinorelbine systemic Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Taxotere Rx D N Add review Rate Generic name: docetaxel systemic Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information erlotinib Rx D N 37 reviews 8.0 Generic name: erlotinib systemic Brand name: Tarceva Drug class: EGFR inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph paclitaxel Rx D N 1 review 8.0 Generic name: paclitaxel systemic Brand name: Taxol Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Trexall Rx X N X Add review Rate Generic name: methotrexate systemic Drug class: antimetabolites , antirheumatics , antipsoriatics , other immunosuppressants For consumers: dosage , interactions , side effects For professionals: Prescribing Information Gilotrif Rx D N 1 review 10 Generic name: afatinib systemic Drug class: multikinase inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information pemetrexed Rx D N 2 reviews 8.0 Generic name: pemetrexed systemic Brand name: Alimta Drug class: antimetabolites For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph Platinol Rx D N Add review 6.0 Generic name: cisplatin systemic Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information vinorelbine Rx D N Add review Rate Generic name: vinorelbine systemic Brand name: Navelbine Drug class: mitotic inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information gefitinib Rx D N 7 reviews 9.0 Generic name: gefitinib systemic Brand name: Iressa Drug class: EGFR inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph nivolumab Rx N 22 reviews 4.0 Generic name: nivolumab systemic Brand name: Opdivo Drug class: Anti-PD-1 monoclonal antibodies For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph Tagrisso Rx N Add review Rate Generic name: osimertinib systemic Drug class: EGFR inhibitors For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information bevacizumab Rx C N 1 review 8.0 Generic name: bevacizumab systemic Brand name: Avastin Drug class: VEGF/VEGFR inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph methotrexate Rx X N X Add review Rate Generic name: methotrexate systemic Brand name: Trexall Drug class: antimetabolites , antirheumatics , antipsoriatics , other immunosuppressants For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information crizotinib Rx D N 4 reviews 9.0 Generic name: crizotinib systemic Brand name: Xalkori Drug class: multikinase inhibitors For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph Page 1 2 3 Next Learn more about Non-Small Cell Lung Cancer Micromedex Care Notes Lung Cancer Non-small Cell Lung Cancer Symptoms and treatments Non-Small Cell Lung Cancer Drugs.com Health Center Lung Cancer Legend Off Label This medication may not be approved by the FDA for the treatment of this condition. Prescription Only / Over the Counter Rx Prescription Only OTC Over the Counter Rx/OTC Prescription or Over the Counter Pregnancy A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. N FDA has not classified the drug. Controlled Substances Act Schedule N Is not subject to the Controlled Substances Act. 1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. 2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. 3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. 4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. 5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. Alcohol X Interacts with Alcohol. Browse Drugs by Condition A B C D E F G H I J K L M N O P Q R S T U V W X Y Z} More Information Care Notes 2 related articles Harvard Health Guide 1 related article Latest FDA Approvals for Non-Small Cell Lung Cancer Mvasi Alunbrig Tecentriq Help and Support Looking for answers? Ask a question or go join the non-small cell lung cancer support group to connect with others who have similar interests.} }
the drugs Medications for Non-Small Cell Lung Cancer many different types
EmoticonEmoticon